Expertise in
3
conditions

Timothy P. Harrower

Exeter, ENG, GB 
Expertise in
3
conditions
Exeter, ENG, GB 

Overview

Timothy Harrower practices practicing medicine in Exeter, United Kingdom.

Mr. Harrower is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Huntington Disease, and Chorea.

He is actively involved in clinical research, co-authoring 25 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Exeter, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)
A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)
Enrollment Status: Completed
Publish Date: August 12, 2025
Intervention Type: Drug
Study Drug: WVE-003
Study Phase: Phase 1/Phase 2
A Phase 3 Randomised, Double Blind, Clinical Trial Investigating the Effectiveness of Repurposed Simvastatin Compared to Placebo, in Secondary Progressive Multiple Sclerosis, in Slowing the Progression of Disability
A Phase 3 Randomised, Double Blind, Clinical Trial Investigating the Effectiveness of Repurposed Simvastatin Compared to Placebo, in Secondary Progressive Multiple Sclerosis, in Slowing the Progression of Disability
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Simvastatin
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease
Enrollment Status: Terminated
Publish Date: April 25, 2022
Intervention Type: Drug
Study Drug: WVE-120102
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease
Enrollment Status: Terminated
Publish Date: February 10, 2022
Intervention Type: Drug
Study Drug: WVE-120101
Study Phase: Phase 1/Phase 2
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
Enrollment Status: Terminated
Publish Date: August 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

25 Total Publications

In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging.
In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging.
Journal: eLife
Published: August 11, 2026

Frequently Asked Questions about Timothy P. Harrower

Is Timothy P. Harrower a top-rated expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)?

MediFind is an objective health platform that identifies experts based on real-world data. Timothy P. Harrower is classified as an Advanced expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Timothy P. Harrower participate in research or clinical trials?

Yes. Timothy P. Harrower has published 25 articles and abstracts on conditions like Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). You can view a list of Timothy P. Harrower's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Harrower's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile